RT Journal Article T1 Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis A1 Mena-Vazquez, Natalia A1 Rojas-Gimenez, Marta A1 Jimenez Nuñez, Francisco Gabriel A1 Manrique-Arija, Sara A1 Rioja, José A1 Ruiz-Limón, Patricia A1 Ureña, Inmaculada A1 Castro-Cabezas, Manuel A1 Valdivielso, Pedro A1 Fernández-Nebro, Antonio K1 Rheumatoid arthritis K1 Postprandial lipemia K1 Apolipoprotein B48 K1 Subclinical atherosclerosis K1 Cross-sectional studies K1 Artritis reumatoide K1 Apolipoproteína B-48 K1 Aterosclerosis K1 Estudios transversales K1 Andalucía AB Objective: To describe postprandial lipemia in patients with rheumatoid arthritis (RA) and to analyze its association with subclinical atherosclerosis measured as carotid intima-media thickness (cIMT). Methods: We performed an observational study of 40 patients with RA and 40 sex and age-matched controls. Patients with dyslipidemia were excluded. Pathologically increased cIMT was defined as a carotid thickness greater than the 90th percentile (>p90) for age and sex. Fasting and postprandial plasma lipids, cholesterol, triglycerides, apolipoprotein B48 (ApoB48), and total ApoB were evaluated. The other variables included were clinical and laboratory values, Framingham score, and the 28-joint Disease Activity Score (DAS28). Two multivariate models were constructed to identify factors associated with pathologic cIMT in patients with RA. Results: Fasting lipid values were similar in patients with RA and controls, although those of postprandial ApoB48 were higher (median (IQR), 14.4 (10.8–12.1) vs. 12.1 (2.3–9,8); p = 0.042). Pathologic cIMT was recorded in 10 patients with RA (25%) and nine controls (22.5%). In patients with RA, pathologic cIMT was associated with postprandial ApoB48 (OR (95% CI), 1.15 (1.0–1.3)) and total ApoB (OR [95% CI], 1.12 [1.1–1.2]). The second model revealed a mean increase of 0.256 mm for cIMT in patients with elevated anticitrullinated protein antibodies (ACPAs). Conclusion: Postprandial ApoB48 levels in patients with RA are higher than in controls. Postprandial ApoB48 and total ApoB levels and markers of severity, such as ACPAs, are associated with pathologic cIMT in patients with RA. Our findings could indicate that these atherogenic particles have a negative effect on the endothelium. PB MDPI YR 2020 FD 2020-08-02 LK http://hdl.handle.net/10668/4081 UL http://hdl.handle.net/10668/4081 LA en NO Mena-Vázquez N, Rojas-Gimenez M, Jimenez Nuñez FG, Manrique-Arija S, Rioja J, Ruiz-Limón P, et al. Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis. J Clin Med. 2020 Aug 2;9(8):2483 DS RISalud RD Apr 8, 2025